Ion Exchange (india) Ltd. · NSE:IONEXCHANG
Ion Exchange (india) — Q3 FY2022 Earnings Presentation
23 slides from Ion Exchange (india)'s earnings presentation, Jan 27, 2022
Slide 1: BSE submission letter for analyst/investor presentation
January 27, 2022 To, BSE Limited The Corporate Relationship Dept. P.J. Towers, Dalal Street, Mumbai-400 001 BSE Company Code: 500214 Dear Sir/ Madam, Sub: Submission of Analyst/ Investor Presentation Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and D
Slide 2: Earnings Presentation – 9M / Q3-FY22
EARNINGS PRESENTATION – 9M / Q3-FY22
Slide 3: Executive Summary
Executive Summary OVERVIEW • Ion Exchange (India) Ltd (Ion Exchange), formed in 1964, is a pioneer in water, waste water treatment & FY21: Operating environment solutions and caters to various industries, institutions, homes & communities. Income* INR 14,495 • Headquartered in Mumbai, the company ha
Slide 4: Company Overview
Company Overview • Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. It FY21 REVENUE BREAKUP* became a wholly owned Indian company in 1985. The company is currently in its 56th Year of operations. • The company has expanded its footprints globally and possesses a diversifie
Slide 5: 9M / Q3-FY22 Financial Highlights
9M / Q3-FY22 Financial Highlights Q3-FY22 Performance (Standalone) Q3-FY22 Performance (Consolidated) INR 3,784 Mn INR 425 Mn 11.23% INR 3,882 Mn INR 427 Mn 11.00% Operating Income Operating EBITDA Operating EBITDA Operating Income Operating EBITDA Operating EBITDA Margins Margins INR 305 Mn 8.06% I
Slide 6: 9M / Q3-FY22 Operational Highlights
9M / Q3-FY22 Operational Highlights ENGINEERING Ø There was an improvement in the order book on the back of the EPC order from Numaligarh Refinery Ltd. coupled with steady flow of medium sized orders during the quarter. Ø Execution of the the Sri Lanka order remained affected during the quarter due
Slide 7: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance INCOME STATEMENT (INR MN) Q3-FY22 Q3-FY21 Y-o-Y Q2-FY22 Q-o-Q Operating Income 3,784 3,338 13.4% 3,647 3.8% Expenses 3,359 2,917 15.2% 3,250 3.4% Operating EBITDA 425 421 1.0% 397 7.1% Operating EBITDA Margins (%) 11.23% 12.61% (138) Bps 10.89% 34 Bps Depre
Slide 8: Segmental Breakup - Quarterly Standalone
Segmental Breakup - Quarterly Standalone ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 1,353 352 E 2,184 1,117 V 2,039 285 E N U E Q3-FY21 Q3-FY22 Q3-FY21 Q3-FY22 Q3-FY21 Q3-FY22 283 Q3-FY21 Q3-FY22 E B 264 (3) I 143 (8) 131 T Q3-FY21 Q3-FY22 Q3-FY21 Q3-FY22 7
Slide 9: YTD Standalone Financial Performance
YTD Standalone Financial Performance INCOME STATEMENT (INR MN) 9M-FY22 9M-FY21 Y-o-Y Operating Income 10,437 9,688 7.7% Expenses 9,250 8,538 8.3% Operating EBITDA 1,187 1,150 3.2% Operating EBITDA Margins (%) 11.37% 11.87% (50) Bps Depreciation 201 198 1.5% Finance Cost 57 79 (27.8)% Other Income 26
Slide 10: Segmental Breakup – YTD Standalone
Segmental Breakup – YTD Standalone ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 941 6,184 3,824 E 3,057 707 V E 6,015 N U E 9M-FY21 9M-FY22 9M-FY21 9M-FY22 9M-FY21 9M-FY22 408 821 9M-FY21 9M-FY22 381 E B 695 I T 9M-FY21 9M-FY22 9M-FY21 9M-FY22 (23) (27) 9
Slide 11: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance INCOME STATEMENT (INR MN) Q3-FY22 Q3-FY21 Y-o-Y Q2-FY22 Q-o-Q Operating Income 3,882 3,492 11.2% 3,782 2.6% Expenses 3,455 3,047 13.4% 3,385 2.1% Operating EBITDA 427 445 (4.0)% 397 7.6% Operating EBITDA Margins (%) 11.00% 12.74% (174) Bps 10.50% 50 Bps D
Slide 12: Segmental Breakup - Quarterly Consolidated
Segmental Breakup - Quarterly Consolidated ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 352 E 2,161 2,168 1,467 285 V E 1,148 N U E Q3-FY21 Q3-FY22 Q3-FY21 Q3-FY22 Q3-FY21 Q3-FY22 Q3-FY21 Q3-FY22 308 E B (2) 160 (7) I 113 268 T Q3-FY21 Q3-FY22 Q3-FY21 Q3-FY22 11
Slide 13: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance INCOME STATEMENT (INR MN) 9M-FY22 9M-FY21 Y-o-Y Operating Income 10,805 10,044 7.6% Expenses 9,623 8,877 8.4% Operating EBITDA 1,182 1,167 1.3% Operating EBITDA Margins (%) 10.94% 11.62% (68) Bps Depreciation 210 211 (0.5)% Finance Cost 75 98 (23.5)% Other Inco
Slide 14: Segmental Breakup – YTD Consolidated
Segmental Breakup – YTD Consolidated ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 6,497 941 E 4,065 707 V 6,143 3,098 E N U E 9M-FY21 9M-FY22 9M-FY21 9M-FY22 9M-FY21 9M-FY22 438 336 9M-FY21 9M-FY22 863 E 672 B I T (20) (23) 9M-FY21 9M-FY22 9M-FY21 9M-FY22 13
Slide 15: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW 14
Slide 16: Historical Standalone Financial Performance
Historical Standalone Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 9M-FY22 Operating Income 11,023 14,072 14,018 10,437 Expenses 10,110 12,862 12,067 9,250 Operating EBITDA 913 1,210 1,951 1,187 Operating EBITDA Margins (%) 8.28% 8.60% 13.92% 11.37% Depreciation 181 221 261 201 Fin
Slide 17: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet PARTICULARS (INR MN) FY20 FY21 H1-FY22 PARTICULARS (INR MN) FY20 FY21 H1-FY22 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 147 147 147 (A) Property, Plant and Equipment 1,385 1,421 1,382 (B) Other Equity 4,668 6,123 6,580 (B) Ca
Slide 18: Historical Consolidated Financial Performance
Historical Consolidated Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 9M-FY22 Operating Income 11,623 14,798 14,495 10,805 Expenses 10,557 13,453 12,472 9,623 Operating EBITDA 1,066 1,345 2,023 1,182 Operating EBITDA Margins (%) 9.17% 9.09% 13.96% 10.94% Depreciation 196 235 277 210
Slide 19: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet PARTICULARS (INR MN) FY20 FY21 H1-FY22 PARTICULARS (INR MN) FY20 FY21 H1-FY22 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 142 142 142 (A) Property, Plant and Equipment 1,459 1,486 1,443 (B) Other Equity 3,489 4,916 5,321 (B)
Slide 20: Consolidated Financial Performance
Consolidated Financial Performance REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) REVENUE EBITDA PAT 14,798 14,495 CAGR 11% CAGR 38% CAGR 53% 2,023 11,623 1,433 10,549 10,805 1,345 1,066 1,182 942 770 785 659 399 FY18 FY19 FY20 FY21 9M-FY22 FY18 FY19 FY20 FY21 9M-FY22 FY18 FY19 FY20 FY21 9
Slide 21: Market Data (Bloomberg – ION IN, Reuters – IONX.BO)
Market Data (Bloomberg – ION IN, Reuters – IONX.BO) 1 YEAR SHARE PRICE MOVEMENT (UP TO 31st December, 2021) 230% 180% 130% 80% 30% -20% Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21 Ion Sensex PRICE DATA (AS ON 31st December, 2021) SHAREHOLDING PATTERN (AS ON 31
Slide 22: Disclaimer
Disclaimer Ion Exchange (India) Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all e
Slide 23: Thank You
THANK YOU
Ion Exchange (India) — Q3 FY2022 Earnings Presentation on 6ix